Concepedia

Publication | Open Access

LBA31 Neoadjuvant nivolumab plus relatlimab (anti-LAG3) in locally advanced MMR-deficient colon cancers: The NICHE-3 study

24

Citations

0

References

2023

Year

No additional data available for this publication yet. Check back later!